Prosecution Insights
Last updated: April 19, 2026

Leadingtac Pharmaceutical (Shaoxing) Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17999798 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF AULAKH, CHARANJIT 1621 Final Rejection Nov 23, 2022
17996734 USE OF IRAK4 INHIBITOR IN TREATMENT OF ACUTE LUNG INJURY ALI/ARDS DAVIS, BRIAN J 1614 Non-Final OA Oct 20, 2022

Managing Leadingtac Pharmaceutical (Shaoxing) Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month